<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Syst Biol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Syst Biol</journal-id><journal-title-group><journal-title>BMC Systems Biology</journal-title></journal-title-group><issn pub-type="epub">1752-0509</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5998874</article-id><article-id pub-id-type="pmid">29745833</article-id><article-id pub-id-type="publisher-id">564</article-id><article-id pub-id-type="doi">10.1186/s12918-018-0564-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Differential networking meta-analysis of gastric cancer across Asian and American racial groups</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dai</surname><given-names>Wentao</given-names></name><address><email>wtdai@scbit.org</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Quanxue</given-names></name><address><email>liqxue@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Bing-Ya</given-names></name><address><email>liubingya@sjtu.edu.cn</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Yi-Xue</given-names></name><address><email>yxli@scbit.org</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Yuan-Yuan</given-names></name><address><email>yyli@scbit.org</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0387 1100</institution-id><institution-id institution-id-type="GRID">grid.58095.31</institution-id><institution>Shanghai Center for Bioinformation Technology, </institution></institution-wrap>1278 Keyuan Road, Shanghai, 201203 People&#x02019;s Republic of China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2163 4895</institution-id><institution-id institution-id-type="GRID">grid.28056.39</institution-id><institution>School of biotechnology, </institution><institution>East China University of Science and Technology, </institution></institution-wrap>Shanghai, 200237 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution>Shanghai Key Laboratory of Gastric Neoplasms, Shanghai Institute of Digestive Surgery, </institution><institution>Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, </institution></institution-wrap>Shanghai, 200025 People&#x02019;s Republic of China </aff><aff id="Aff4"><label>4</label>Shanghai Engineering Research Center of Pharmaceutical Translation &#x00026; Shanghai Industrial Technology Institute, 1278 Keyuan Road, Shanghai, 201203 People&#x02019;s Republic of China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000000119573309</institution-id><institution-id institution-id-type="GRID">grid.9227.e</institution-id><institution>Key Lab of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, </institution><institution>Chinese Academy of Sciences, </institution></institution-wrap>Shanghai, 200031 China </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>12</volume><issue>Suppl 4</issue><issue-sponsor>Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.</issue-sponsor><elocation-id>51</elocation-id><permissions><copyright-statement>&#x000a9; The Author(s). 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Gastric Carcinoma is one of the most lethal cancer around the world, and is also the most common cancers in Eastern Asia. A lot of differentially expressed genes have been detected as being associated with Gastric Carcinoma (GC) progression, however, little is known about the underlying dysfunctional regulation mechanisms. To address this problem, we previously developed a differential networking approach that is characterized by involving differential coexpression analysis (DCEA), stage-specific gene regulatory network (GRN) modelling and differential regulation networking (DRN) analysis.</p></sec><sec><title>Result</title><p id="Par2">In order to implement differential networking meta-analysis, we developed a novel framework which integrated the following steps. Considering the complexity and diversity of gastric carcinogenesis, we first collected three datasets (GSE54129, GSE24375 and TCGA-STAD) for Chinese, Korean and American, and aimed to investigate the common dysregulation mechanisms of gastric carcinogenesis across racial groups. Then, we constructed conditional GRNs for gastric cancer corresponding to normal and carcinoma, and prioritized differentially regulated genes (DRGs) and gene links (DRLs) from three datasets separately by using our previously developed differential networking method. Based on our integrated differential regulation information from three datasets and prior knowledge (e.g., transcription factor (TF)-target regulatory relationships and known signaling pathways), we eventually generated testable hypotheses on the regulation mechanisms of two genes, XBP1 and GIF, out of 16 common cross-racial DRGs in gastric carcinogenesis.</p></sec><sec><title>Conclusion</title><p id="Par3">The current cross-racial integrative study from the viewpoint of differential regulation networking provided useful clues for understanding the common dysfunctional regulation mechanisms of gastric cancer progression and discovering new universal drug targets or biomarkers for gastric cancer.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s12918-018-0564-z) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Gastric carcinoma (GC)</kwd><kwd>Differential networking meta-analysis</kwd><kwd>Cross-racial</kwd><kwd>Conditional gene regulatory networks (GRN)</kwd><kwd>Dysfunctional regulation mechanisms</kwd></kwd-group><conference xlink:href="http://www.aporc.org/ISB/2017/"><conf-name>The 11th International Conference on Systems Biology (ISB 2017)</conf-name><conf-loc>Shenzhen, China</conf-loc><conf-date>18-21 August 2017</conf-date></conference><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par13">Gastric Carcinoma (GC) is one of the most common and lethal tumor around the world, which is characterized by high heterogeneity, easy metastasis, and poor prognosis [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The morbidity and mortality of gastric carcinoma in Eastern Asia are much higher than the world average level [<xref ref-type="bibr" rid="CR3">3</xref>]. During the last decade, quite a series of high-throughput profiling, including genetic variation study [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>], genome-wide association study (GWAS) [<xref ref-type="bibr" rid="CR7">7</xref>], gene expression analysis [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref>], epigenetic variation study [<xref ref-type="bibr" rid="CR11">11</xref>], and integrative genomic analysis [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref>], have greatly help to understand the biology of GC, and identified quite a lot of GC-associated genes. It was noticed that the above studies always collected GC samples from a certain racial group such as Chinese [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], Korean [<xref ref-type="bibr" rid="CR8">8</xref>], and American [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR17">17</xref>], respectively, while the common dysregulation mechanisms of gastric carcinogenesis across racial groups has been paid little attention due to lack of integration research based on cross-racial GC datasets.</p><p id="Par14">It has been widely accepted that cancer results from the dysregulation of multiple fundamental cell processes including proliferation, differentiation, migration, apoptosis, and so on [<xref ref-type="bibr" rid="CR18">18</xref>], which could be captured by gene regulatory network (GRN) modelling, a widely used approach to explore the pathogenesis of complex diseases from the systemic aspect [<xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref>]. In recent years, a novel theme &#x0201c;differential networking&#x0201d; was put forward and a number of methods have been developed to identify the regulators, the relationships, and even the sub-networks that differ between phenotypes [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>]. With the rapid accumulation of transcriptomic data, differential network analysis is helpful to survey the dynamics of gene regulation, which is crucial to the understanding of pathophysiological processes [<xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>]. In our previous studies, we designed and implemented a differential co-expression analysis (DCEA) approach called DCGL to recognize differential co-expression genes (DCGs) and links (DCLs) in a link-based quantitative way [<xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR29">29</xref>]. Based on this methodology, we further developed a differential regulation networking (DRN) framework [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], which built conditional gene regulatory network (GRN) or combinatorial GRN (cGRN) and then prioritized differentially regulated genes (DRGs) and links (DRLs). Our DRN strategy proves to substantially reduce the computational burden and leads to insightful comments on selecting subject related genes and their differential regulation mechanisms underlying phenotypic changes.</p><p id="Par15">Based on the previous methodologies, the current study aimed at investigating the common dysregulation mechanisms of gastric carcinogenesis across Chinese, Korean and American. To this end, we constructed a novel integrative analysis framework from the viewpoint of differential regulation, which integrated a variety of modules with differential regulation networking (DRN) analysis and integrative analysis as the core steps. First of all, the conditional gene regulation networks (GRN) were built from three Gastric Carcinoma datasets (GSE54129, GSE24375 and TCGA-STAD) separately, and differentially regulated genes (DRGs) and differentially regulated links (DRLs) were prioritized then. It was found that known cancer genes and drug targets are significantly ranked higher, and most of top-10 DRGs from the three datasets have been reported to be GC related (~&#x02009;60%), or cancer related (~&#x02009;90%); meanwhile, there is a lack of consistency among the three top DRG lists. By integrating DRGs and DRLs from three datasets to the prior regulation knowledge, it was found that the 16 common DRGs across racial groups are mainly located in the transcription factor complex in nucleus and their functions were enriched in transcriptional regulation of RNA polymerase II, transcriptional activator activity and transcription factor binding. We therefore proposed two common cross-racial DRGs (GIF, XBP1) and their related regulation relationships which might play crucial roles in the dysregulation mechanisms of gastric carcinogenesis. This integration analysis of GC across racial groups provided useful clues for understanding common dysfunctional regulation mechanisms of gastric carcinogenesis and discovering new universal drug targets or biomarkers for gastric cancer, and also indicated the complexity and diversity of gastric carcinogenesis as well.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Gene expression datasets</title><p id="Par16">The Affymetrix GeneChip Operating System (GCOS) was used to measure expression level of 111 Chinese gastric carcinoma samples and 21 Chinese normal mucosa samples (GSE54129). The raw expression datasets were normalized by robust RMA method and log2 transformed. The evaluation of GSE54129 raw data in terms of expression level distribution, density distribution and correlations of samples were shown in Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S1. After mapping probe sets to Gene Symbols based on their platform annotations, 20,307 unique genes were obtained.</p><p id="Par17">We also downloaded the mRNA expression dataset of stomach adenocarcinoma (STAD) from The Cancer Genome Atlas (TCGA) Data Protal (<ext-link ext-link-type="uri" xlink:href="https://cancergenome.nih.gov/">https://cancergenome.nih.gov/</ext-link>), which contains sequenced 29 matched American tumor-normal pairs with Illumina Hiseq platform. After discarding genes with more than 20% missing values, we got 19,211 RPKM normalized and log2 transformed unique genes.</p><p id="Par18">The normalized gene expression profile of Korean gastric carcinoma GSE24375 [<xref ref-type="bibr" rid="CR7">7</xref>] was downloaded from Gene Expression Omnibus (GEO) and all measurements were log2 transformed. The dataset includes eight patient-matched gastric normal mucosa, adenoma and carcinoma samples and two additional carcinoma samples. Probe sets with more than 20% missing values were discarded, while probe sets with less missing values were filled up with KNN method. After probe sets filtering, 18,468 probe sets were mapped to Gene Symbols based on their platform annotations and 12,658 unique genes were obtained. The distributions of normalized and log2 transformed expression levels of genes in three datasets are presented in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2.</p></sec><sec id="Sec4"><title>Enrichment analysis: Function, pathway, cancer genes and drug targets</title><p id="Par19">The Database for Annotation, Visualization and Integrated Discovery (DAVID) [<xref ref-type="bibr" rid="CR32">32</xref>] was used to identify over-represented KEGG pathways and GO terms based on the hypergeometric distribution with <italic>p</italic>-values &#x0003c;&#x02009;0.05 were considered statistically significant.</p><p id="Par20">A total of 486 cancer genes and 2093 drug targets were downloaded from Cancer Gene Census (<ext-link ext-link-type="uri" xlink:href="http://cancer.sanger.ac.uk/cancergenome/projects/census">http://cancer.sanger.ac.uk/cancergenome/projects/census/</ext-link>) and DrugBank (<ext-link ext-link-type="uri" xlink:href="http://www.drugbank.ca">http://www.drugbank.ca</ext-link>/), respectively, which were used to validate the differential regulation analysis on the three gene expression datasets.</p></sec><sec id="Sec5"><title>Differential networking meta-analysis framework</title><p id="Par22">In order to implement differential networking meta-analysis, we developed a novel framework which integrated a variety of modules as follows (outlined in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3).</p><p id="Par23">Differentially co-expressed genes (DCGs) and links (DCLs) were identified with our previously developed differential coexpression analysis (DCEA) methods [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. DCGs with <italic>p-</italic>values less than 0.05 were selected by DCp method, and DCLs were picked out by DCe method with LFC model in DCGL package [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par24">The conditional gene regulatory networks (GRN) were constructed for the three preprocessed datasets respectively based on DCGs and DCLs by using the conditional GRN modelling approach developed in our previous work [<xref ref-type="bibr" rid="CR30">30</xref>]. First, we applied DCGL package to the expression dataset (GSE54129, GSE24375 and TCGA-STAD, respectively) to extract differentially coexpressed genes (DCGs) and differentially coexpressed gene links (DCLs) between normal and cancer. The DCGs and the gene pairs in the DCLs which involved at least one DCG between normal and carcinoma were selected as core seeds for the construction of conditional GRNs. Then we constructed the conditional GRNs based on forward predicted TF-target regulatory relationships and the core seed genes by using stepwise linear regression according to our previous method [<xref ref-type="bibr" rid="CR30">30</xref>]. In this way, we built three normal and cancer GRN pairs corresponding to the three expression datasets (GSE54129, GSE24375 and TCGA-STAD) separately.</p><p id="Par25">The differential regulated genes (DRGs) and links (DRLs) in conditional GRNs were ranked by our previously developed quantitatively methods [<xref ref-type="bibr" rid="CR30">30</xref>], DR measure and modified LFC model, respectively. The power of the above two methods in cancer genes and drug targets prioritization have been validated strictly in our previous work. In order to further test the power of prioritization of DRGs and DRLs methods in the three GRN pairs from 3 GC gene expression datasets, we carried out permutation tests by randomly perturbing the DRGs lists for 5000 times for each gene expression dataset as similar as the method described previously [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par26">The integrative analysis was carried out based on both genes and functions. In order to prioritize common DRGs across gastric cancer datasets, we combined DRG lists from the three GC datasets to select cross-racial DRGs which listed in the top N (&#x0003c;&#x02009;100) DRGs commonly in at least two racial groups. To globally understand the common functional relevance of differential regulation across all the three GC datasets, we performed GO/KEGG functional enrichment analysis on both top 10 DRGs out of every single dataset and common cross-racial DRGs by using DAVID 6.8.</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>Screening for differentially co-expressed genes</title><p id="Par27">According to DCGL method [<xref ref-type="bibr" rid="CR28">28</xref>], the genes with the <italic>p</italic>-value of dC less than 0.05 were taken as DCGs between normal and carcinoma. A total of 3875 DCGs were selected from GSE54129 dataset; 3604 DCGs from TCGA-STAD dataset; and 2524 DCGs from GSE24375 dataset.</p><p id="Par28">The intersection and enrichment significance among three DCG sets (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) shows that the DCGs between every two datasets are significantly overlapped by Kappa test. This suggests a basically coherent profile of molecular interactions underlying gastric carcinogenesis across racial groups included in this study, Chinese, Korean, and American.<fig id="Fig1"><label>Fig. 1</label><caption><p>The intersection and enrichment significance among three DCG sets selected from GSE54129 (Chinese, yellow), GSE24375 (Korean, green) and TCGA-STAD (American, cyan) gastric cancer datasets</p></caption><graphic xlink:href="12918_2018_564_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec8"><title>Construction of GRNs and identification of DRGs and DRLs</title><p id="Par29">Based on the (normal and carcinoma) expression data of the selected DCG sets, we built paired conditional (normal and carcinoma) GRNs (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) respectively corresponding to Chinese (GSE54129), Korean (GSE24375) and American (TCGA-STAD) by using the method described in the section of Materials and methods. The statistics of the three pairs of GRNs are listed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.It was found that the paired GRNs, i.e., normal and carcinoma GRNs for a certain dataset, always share the same regulators and most of the target genes, however, they share only a few of links, indicating that our analysis method did efficiently narrow down the search space and build stage-specific networks enriching subject relevant regulation relationships as expected [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. We then checked the global topological change between normal and cancer GRNs across the three datasets. According to the node number, the network size for Chinese (GSE54129) and Korean (GSE24375) expanded from normal to cancer, while that for American (TCGA-STAD) shrank. According to the average degree of nodes, the network complexity for Chinese (GSE54129) increased from normal to cancer, while that for Korean (GSE24375) and American (TCGA-STAD) decreased. Considering the inconsistency of the sample size of the three datasets, the above observation need to be further evaluated based on data from larger patient populations.<fig id="Fig2"><label>Fig. 2</label><caption><p>The normal and carcinoma conditional gene regulation networks (GRNs) for GSE54129 (Chinese), GSE24375 (Korean) and TCGA-STAD (American) gastric cancer datasets</p></caption><graphic xlink:href="12918_2018_564_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Statistics of conditional GRNs from three datasets</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="3">GSE54129</th><th colspan="3">TCGA-STAD</th><th colspan="3">GSE24375</th></tr></thead><tbody><tr><td>GRNs</td><td>Links (#)</td><td>TFs (#)</td><td>Targets (#)</td><td>Links (#)</td><td>TFs (#)</td><td>Targets (#)</td><td>Links (#)</td><td>TFs (#)</td><td>Targets (#)</td></tr><tr><td>Normal</td><td>1621</td><td>30</td><td>1242</td><td>2109</td><td>21</td><td>1462</td><td>878</td><td>22</td><td>507</td></tr><tr><td>Carcinoma</td><td>2725</td><td>30</td><td>1657</td><td>1071</td><td>21</td><td>797</td><td>816</td><td>22</td><td>564</td></tr><tr><td>shared by normal and carcinoma GRNs</td><td>723</td><td>30</td><td>972</td><td>760</td><td>21</td><td>718</td><td>303</td><td>22</td><td>331</td></tr></tbody></table></table-wrap></p><p id="Par30">As shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, known cancer genes and drug targets were enriched in all the conditional GRNs by Fisher&#x02019;s Exact Test, demonstrating that our conditional GRNs have the potential to highlight crucial cancer-related regulation relationships, thus proving the rationality of the three GRN pairs.<table-wrap id="Tab2"><label>Table 2</label><caption><p>The enrichment of cancer genes and drug targets in conditional GRNs</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="2">GSE54129</th><th colspan="2">TCGA</th><th colspan="2">GSE24375</th></tr></thead><tbody><tr><td>GRNs</td><td>Cancer Genes</td><td>Drug Targets</td><td>Cancer Genes</td><td>Drug Targets</td><td>Cancer Genes</td><td>Drug Targets</td></tr><tr><td>Normal</td><td>8.40E-10</td><td>2.84E-13</td><td>0.00012</td><td>6.776e-08</td><td>0.0034</td><td>0.039</td></tr><tr><td>Carcinoma</td><td>2.48E-12</td><td>2.21E-10</td><td>2.08E-6</td><td>4.841e-07</td><td>0.0015</td><td>0.0002</td></tr></tbody></table><table-wrap-foot><p>Enrichment significance (<italic>p</italic>-value) was calculated by Fisher Exact Test</p></table-wrap-foot></table-wrap></p><p id="Par31">After constructing conditional GRNs, a key issue is to quantitatively analyze the dynamic changes of gene regulation during phenotypic changes, i.e., from normal to carcinoma in the current work. Two methods were used to measure the differential regulation of a specific gene or gene link between two conditional GRNs as described in the section of Materials and methods, based on which differentially regulated genes (DRGs) and differentially regulated gene pairs or links (DRLs) were prioritized.</p><p id="Par32">Permutation test showed that gastric cancer genes were significantly ranked higher in the DRG lists from three GC expression datasets, with <italic>p</italic>-values of 1.36e-05 (GSE24375), 6.54e-53 (GSE54129) and 0.00793 (TCGA-STAD). The rank of drug targets in these DRG lists presented a similar trend, though not significant in datasets GSE24375 and TCGA-STAD. This indicates that DR ranking is appropriate to prioritize disease related genes in the current conditional GRNs.</p><p id="Par33">The top 10 DRGs identified from three GC expression datasets were listed in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>. Among the top 10 DRGs for Chinese (GSE54129), six genes have been reported to be gastric cancer (GC) related (REG4 [<xref ref-type="bibr" rid="CR34">34</xref>], ANXA13 [<xref ref-type="bibr" rid="CR35">35</xref>], C7 [<xref ref-type="bibr" rid="CR36">36</xref>], ASS1 [<xref ref-type="bibr" rid="CR37">37</xref>], MSMB [<xref ref-type="bibr" rid="CR38">38</xref>], CREB1 [<xref ref-type="bibr" rid="CR39">39</xref>]) and the rest four were directly regulated by known gastric cancer genes in our GRNs, in which two genes are also cancer related (BPTF [<xref ref-type="bibr" rid="CR40">40</xref>], CLCA1 [<xref ref-type="bibr" rid="CR41">41</xref>]). Among the top 10 DRGs identified for Korean (GSE24375), six genes are GC related (ESRRG [<xref ref-type="bibr" rid="CR42">42</xref>], LIMS1 [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>], GATA3 [<xref ref-type="bibr" rid="CR45">45</xref>], GATA6 [<xref ref-type="bibr" rid="CR46">46</xref>], SOX9 [<xref ref-type="bibr" rid="CR47">47</xref>], POU2F1 [<xref ref-type="bibr" rid="CR48">48</xref>]) and the other four are cancer related (IRF2 [<xref ref-type="bibr" rid="CR49">49</xref>], RGS3 [<xref ref-type="bibr" rid="CR50">50</xref>], MRPL36 [<xref ref-type="bibr" rid="CR51">51</xref>], FOSB [<xref ref-type="bibr" rid="CR52">52</xref>]). Among the top 10 DRGs identified from TCGA-STAD dataset, six are GC related (E2F1 [<xref ref-type="bibr" rid="CR50">50</xref>], AK1B10 [<xref ref-type="bibr" rid="CR51">51</xref>], CEBPA [<xref ref-type="bibr" rid="CR52">52</xref>], PTK7 [<xref ref-type="bibr" rid="CR53">53</xref>], RASAL1 [<xref ref-type="bibr" rid="CR54">54</xref>], GKN [<xref ref-type="bibr" rid="CR55">55</xref>]), and three are cancer related (DPCR1 [<xref ref-type="bibr" rid="CR56">56</xref>], GGT6 [<xref ref-type="bibr" rid="CR57">57</xref>], RAB25 [<xref ref-type="bibr" rid="CR58">58</xref>]). Additionally, 873 DRLs, 590 DRLs and 319 DRLs were identified for Chinese (GSE54129), American (TCGA-STAD) and Korean (GSE24375), respectively (Additional&#x000a0;file&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>: Table S1). We noticed that the vast majority of top 10 DRGs are gastric cancer related in all three datasets, while the three gene lists do not overlap at all, suggesting that the most crucial factors during gastric carcinogenesis may vary across racial groups. We therefore carried out the following integrative analysis aiming to identify cross-racial dysregulation mechanisms underlying gastric carcinogenesis.<table-wrap id="Tab3"><label>Table 3</label><caption><p>The top 10 ranked genes from three datasets</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3">TCGA-STAD</th><th colspan="3">GSE54129</th><th colspan="3">GSE24375</th></tr></thead><tbody><tr><td>DRGs</td><td>DR_value</td><td>rank</td><td>DRGs</td><td>DR_value</td><td>rank</td><td>DRGs</td><td>DR_value</td><td>rank</td></tr><tr><td>
<bold>E2F1</bold>
</td><td>18.45799</td><td>1</td><td>SLC7A9</td><td>65.03438</td><td>1</td><td>
<bold>LIMS1</bold>
</td><td>3401.341</td><td>1</td></tr><tr><td>
<bold>AKR1B10</bold>
</td><td>15.58216</td><td>2</td><td>
<bold>REG4</bold>
</td><td>22.26006</td><td>2</td><td>
<italic>FOSB</italic>
</td><td>582.8947</td><td>2</td></tr><tr><td>
<bold>CEBPA</bold>
</td><td>12.34533</td><td>3</td><td>
<italic>BPTF</italic>
</td><td>20.02962</td><td>3</td><td>
<italic>MRPL36</italic>
</td><td>261.5739</td><td>3</td></tr><tr><td>
<bold>PTK7</bold>
</td><td>11.85102</td><td>4</td><td>DHRS11</td><td>19.11607</td><td>4</td><td>
<bold>ESRRG</bold>
</td><td>247.57</td><td>4</td></tr><tr><td>PLAU</td><td>11.5865</td><td>5</td><td>
<bold>ANXA13</bold>
</td><td>17.92791</td><td>5</td><td>
<bold>GATA3</bold>
</td><td>132.0578</td><td>5</td></tr><tr><td>
<italic>DPCR1</italic>
</td><td>11.37501</td><td>6</td><td>
<bold>C7</bold>
</td><td>15.36403</td><td>6</td><td>
<bold>GATA6</bold>
</td><td>85.31825</td><td>6</td></tr><tr><td>
<italic>GGT6</italic>
</td><td>11.14235</td><td>7</td><td>
<bold>ASS1</bold>
</td><td>15.10191</td><td>7</td><td>
<bold>SOX9</bold>
</td><td>47.91384</td><td>7</td></tr><tr><td>RAB25</td><td>9.645954</td><td>8</td><td>
<bold>MSMB</bold>
</td><td>13.03145</td><td>8</td><td>
<bold>POU2F1</bold>
</td><td>41.98352</td><td>8</td></tr><tr><td>
<bold>RASAL1</bold>
</td><td>9.191246</td><td>9</td><td>
<italic>CLCA1</italic>
</td><td>12.91625</td><td>9</td><td>
<italic>IRF2</italic>
</td><td>37.68406</td><td>9</td></tr><tr><td>
<bold>GKN2</bold>
</td><td>8.602126</td><td>10</td><td>
<bold>CREB1</bold>
</td><td>12.84939</td><td>10</td><td>
<italic>RGS3</italic>
</td><td>35.60814</td><td>10</td></tr></tbody></table><table-wrap-foot><p>The genes are sorted by DR value. Genes in bold refer to GC-related genes; genes in italic refer to cancer-related genes</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>Integrative analysis of cross-racial DRGs and the proposed mechanisms</title><p id="Par34">In order to prioritize common DRGs across gastric cancer datasets, we combined the three DRG lists from the three GC datasets in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>. Since there are no common DRGs within the top 50 DRG lists among the three datasets, we first checked the overlap between every two datasets. As shown in Table <xref rid="Tab4" ref-type="table">4</xref>, CEBPA, GATA6, GATA3 and GIF genes appear in the top 30 DRGs commonly in at least two different GC datasets, i.e., two racial groups; similarly, GIF, XBP1, CEBPA, GATA6, DPP4, PTK7 and GATA3 appear in the top 50 DRGs. There are 16 cross-racial DRGs in the top 100 DRGs commonly in at least two racial groups, including GIF, XBP1, CEBPA, GATA6, DPP4, PTK7, GATA3, FOSB, EPAS1, CCND2, MALL, IRF1, SOX9, VILL, GALNT3 and LGALS4. The number of TOP N (&#x0003c;=100) overlapping DRGs across racial groups are not significantly different as shown in Table <xref rid="Tab4" ref-type="table">4</xref>. Meanwhile, we also noticed that among a total number of 6399 DCGs for Chinese and Korean, 12% (769) were shared by the two DCG lists; among 7479 DCG for American and Korean, 10.7% (803) were shared; while among 6128 DCG for Chinese and American, 7.8% (480) were shared (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). This suggests that Chinese and Korean have similar gastric carcinogenesis, compared with American.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Intersection of top ranked DRGs between every two datasets</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Top10</th><th>Top20</th><th>Top30</th><th>Top40</th><th>Top50</th><th>Top100</th></tr></thead><tbody><tr><td>
<bold>TCGA-STAD vs GSE54129</bold>
</td><td>0</td><td>CEBPA</td><td>
<bold>CEBPA</bold>
</td><td>CEBPA</td><td>CEBPA</td><td>CEBPA/GIF/XBP1</td></tr><tr><td>
<bold>GSE54129 vs GSE24375</bold>
</td><td>0</td><td>GATA6</td><td>
<bold>GATA6</bold>
</td><td>GATA6</td><td>GATA6/DPP4</td><td>GATA6/GIF/FOSB/XBP1/DPP4/EPAS1/CCND2/MALL</td></tr><tr><td>
<bold>TCGA-STAD vs GSE24375</bold>
</td><td>0</td><td>0</td><td>
<bold>GATA3/GIF</bold>
</td><td>GIF/GATA3/PTK7</td><td>GIF/GATA3/PTK7/XBP1</td><td>GIF/GATA3/PTK7/XBP1/IRF1/SOX9/VILL/GALNT3/LGALS4</td></tr><tr><td>
<bold>Across 3 datasets</bold>
</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>
<bold>GIF/XBP1</bold>
</td></tr></tbody></table><table-wrap-foot><p>GSE54129, GSE24375 and TCGA-STAD collected Chinese, Korean and American gastric cancer samples respectively. The overlaps of top ranked differentially regulated genes (DRGs) between any two datasets (Row 2nd, 3rd and 4th) and between all three datasets (Row 5th) are listed</p></table-wrap-foot></table-wrap></p><p id="Par35">To globally understand the common functional relevance of differential regulation across the three GC datasets, we performed GO/KEGG functional enrichment analysis on the top ranked DRGs (as shown in Tables&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>) by using DAVID 6.8 [<xref ref-type="bibr" rid="CR32">32</xref>]. First, the TOP 10 DRGs from three GC dataset (GSE54129, GSE24375 and TCGA-STAD) were analyzed separately. However, no GO/KEGG terms were significantly enriched in any of the three gene sets after multiple hypothesis test correction. Secondly, the terms &#x0201c;transcription regulatory region DNA binding&#x0201d; and &#x0201c;RNA polymerase II transcription factor binding&#x0201d; were identified based on seven common TOP-50 DRGs (GIF, XBP1, CEBPA, GATA6, DPP4, PTK7 and GATA3) between at least two GC datasets. Similarly, based on 16 common TOP-100 DRGs, the terms of &#x0201c;transcription from RNA polymerase II promoter&#x0201d;, &#x0201c;positive regulation of transcription from RNA polymerase II promoter&#x0201d;, &#x0201c;transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding&#x0201d;, &#x0201c;sequence-specific DNA binding&#x0201d;, &#x0201c;transcription factor complex&#x0201d; and &#x0201c;nucleoplasm&#x0201d; were recognized. That is, the 16 common DRGs across racial groups are mainly located in the transcription factor complex in nucleus and their functions were enriches in transcriptional regulation of RNA polymerase II, transcriptional activator activity and transcription factor binding. This is consistent with the basic understanding that transcription factors (TFs) play crucial roles in the proliferation and differentiation of cells.</p><p id="Par36">It is interesting that GIF, the overlapping gene in the three top-100 gene lists across Chinese, Korean, and American, which is also a TOP-30 DRG commonly in at least two racial groups, was reported to be a prognosis biomarker of gastric cancer and its decreased expression was reported to be correlated with the progresses of gastritis [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. The down-expression of GIF in gastric carcinoma samples was indeed observed in all three GC dataset. We proposed GIF might be a common GC related gene across racial groups, which participates in carcinogenesis by differential regulation. We then focused on GIF and its surrounding DRLs to generate hypotheses on the regulation mechanisms of gastric carcinogenesis. In our integrative DRN analysis, GIF were regulated by GATA3 in GSE24375 (&#x02212;&#x02009;2.896 vs 0.01; DRL TOP 25) and TCGA-STAD (2.893 vs &#x02212;&#x02009;0.01; DRL TOP7) datasets but their regulation efficacy changes were not consistent. However, GIF was regulated by CEBPA in GSE54129 (&#x02212;&#x02009;3.412 vs 0.01; DRL TOP7). It was noticed that the DRLs of GIF were all ranked in TOP 30 in every dataset. According to the clinical information of TCGA-STAD, the GIF expression in different patient groups based on Neoplasm Histologic Grade were significantly different with Kruskal Wallis Test <italic>p</italic>-value 0.002 as shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S4. We therefore suggest that GIF and its regulation are worthy of further investigation to elucidate its role in gastric carcinogenesis in diverse racial groups.</p><p id="Par37">XBP1 is the only overlapping transcription factor (TF) in the three top-100 gene lists across the three racial groups included in our analysis. Considering the crucial roles of TF in cancer progression, we put much attention to XBP1 although its DR rank and surrounding DRLs are all out of TOP-30 in every dataset and the mutation frequency of XBP1 is low (0.9%) in 588 gastric cancer samples in ICGC database (<ext-link ext-link-type="uri" xlink:href="https://icgc.org/">https://icgc.org/</ext-link>). By integrating our differential regulation analysis results to the prior knowledge, the dysfunctional regulation mechanisms underlying gastric carcinogenesis around XBP1 were proposed in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. In all the three GC datasets, the positive regulation of PPP1R1B by XBP1 was increased from normal to cancer, and the negative regulation of FKBP11 by XBP1 was strengthened. The up-regulation of PPP1R1B was reported to inhibit apoptosis through NF-&#x003ba;B/FLIP(S) pathway [<xref ref-type="bibr" rid="CR55">55</xref>] and promote cell invasion [<xref ref-type="bibr" rid="CR56">56</xref>] and gastric tumorigenesis [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. The down-regulation of FKBP11 leads to the inhibition of autophagy through MTOR pathway and induces carcinogenesis [<xref ref-type="bibr" rid="CR59">59</xref>]. In Chinese and Korean datasets (GSE54129 and GSE24375), the positive regulation of GATA6 by XBP1 was increased from normal to cancer, while it was decreased in American dataset (TCGA-STAD) during carcinogenesis. This might contribute to the differential gastric carcinogenesis between Asian and American. It is interesting that the positive regulation of CA9 by GATA6 was decreased in all three racial groups. This is consistent with the observation that Ca9 expression was frequently lost in gastric cancers in part by methylation [<xref ref-type="bibr" rid="CR60">60</xref>], while contradictory to another report that the activity of Ca9 contributes to invasion and thus advanced tumor progression in a subset of gastric cancers [<xref ref-type="bibr" rid="CR60">60</xref>&#x02013;<xref ref-type="bibr" rid="CR62">62</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p>The hypotheses of dysfunctional regulation mechanisms of gastric carcinogenesis around XBP1. Red ellipses and green rectangles are TFs and targets obtained from our analysis respectively. The red line represents an increased positive regulation from normal to cancer, which also includes a decreased negative regulation; the green line represents a strengthened negative regulation from normal to cancer, which includes a decreased positive regulation as well. The dash line indicates the regulation relationship which exists in all three datasets while with differential regulation efficacy change. The orange ellipses, the white rectangles and the bottom blue rectangles are genes, pathway and cancer related biological processes obtained from the prior knowledge. As for the dark lines, &#x02018;&#x02192;&#x02019; indicates promoted effect; &#x02018;&#x02014;&#x02018;indicts protein-protein interaction; &#x02018;-|&#x02019; indicates inhibited effect</p></caption><graphic xlink:href="12918_2018_564_Fig3_HTML" id="MO3"/></fig></p></sec></sec><sec id="Sec10"><title>Discussion</title><p id="Par38">In this work, we carried out a cross-racial integrative research on gastric cancer in terms of dysfunctional regulation mechanisms by implementing a novel differential networking meta-analysis framework. Differential regulation networking (DRN) analysis aims to identify the regulatory relationships relevant or even causative to phenotypic changes, which is challenging in the field of both computational and experimental biology. Since cancer has a nature of dysregulation mechanisms during carcinogenesis, the DRN analysis is helpful for deciphering differential regulation and differential networking underlying phenotypic changes in cancer. Even if lots of attention has been paid on traditional differential expression analysis in the past carcinogenesis studies, only in very recent years differential regulation networking analysis has become more and more widely applied [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. With the transcriptomic data from cancer samples increasingly accumulated in the public domain, it is time to investigate the common dysfunctional regulation mechanisms of carcinogenesis at a broader systematic level. We therefore created a differential networking meta-analysis framework based on our previously developed metholologies, and applied it to three GC gene expression datasets corresponding to Chinese, Korean and American.</p><p id="Par39">First of all, the high rank of cancer genes and drug targets in the three DRG lists (Table <xref rid="Tab2" ref-type="table">2</xref>) as well as the basic statistics of the three conditional GRN pairs (Table <xref rid="Tab1" ref-type="table">1</xref>) proved the rationality of the whole modelling strategy and the effectiveness of DR measure as expected. Since the DRN analysis module in the framework enables the discovery of novel regulators or regulatory relationships that have not yet been associated to the disease of interest [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR63">63</xref>&#x02013;<xref ref-type="bibr" rid="CR65">65</xref>], we hoped to find out novel dysregulation regulators and their related mechanisms underlying gastric carcinogenesis across different racial groups.</p><p id="Par40">In our framework, DCGs were taken as the seed genes for differential network construction. As shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>, the DCGs between every two datasets are significantly overlapped, indicating a basically coherent profile of molecular interactions across Chinese, Korean, and American; meanwhile, we also noticed a closer overlap between Chinese and Korean, which was supported by previous reports [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. It is interesting that from the viewpoint of gene regulatory network (GRN), the three GRN pairs present significant differences from network topologies to DRG identities (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Furthermore, the consistency of highly ranked DRGs across three racial groups is quite limited as shown in Tables <xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>. The difference between racial groups could be associated with genetics, diet habits and other environmental factors. These observations strongly support the necessity of integrative studies in terms of differential regulation.</p><p id="Par41">In order to decipher the common carcinogenesis across racial groups, we focus on those common DRGs across datasets. The DRGs commonly in at least two racial groups were presented in Table <xref rid="Tab4" ref-type="table">4</xref>. Four genes (CEBPA, GATA6, GATA3 and GIF) were selected from TOP30 DRG lists, seven genes (GIF, XBP1, CEBPA, GATA6, DPP4, PTK7 and GATA3) were selected from TOP50 DRG lists, and 16 genes (GIF, XBP1, CEBPA, GATA6, DPP4, PTK7, GATA3, FOSB, EPAS1, CCND2, MALL, IRF1, SOX9, VILL, GALNT3 and LGALS4) were selected from TOP100 DRGs. Among the 16 cross-racial DRGs, all are cancer related according to ICGC and three genes (GATA3, SOX9 and CEBPA) have been regarded as cancer driver genes [<xref ref-type="bibr" rid="CR68">68</xref>&#x02013;<xref ref-type="bibr" rid="CR71">71</xref>]. Functional enrichment analysis indicated that the 16 common cross-racial DRGs were enriched in the function of transcriptional regulation. We therefore propose that the highly ranked TFs among the 16 top common DRGs, including XBP1, FOSB, MRPL36, GATA3, GATA6, SOX9, POU2F1, IRF2, PTK7, EPAS1 and IRF1 (Table <xref rid="Tab4" ref-type="table">4</xref>) are worthy of further investigation, especially on their roles of gene transcriptional regulation.</p><p id="Par42">We then narrowed down our attention to GIF and XBP1 out of the 16 DRGs. Considering that GIF has been reported to be a GC prognosis biomarker [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>], and GIF&#x02019;s DRLs were all ranked in TOP 30 in every dataset, we suggest that GIF and its regulation are worthy of further investigation to elucidate its role in gastric carcinogenesis. The transcriptional regulation of GIF by GATA3 and CEBPA might be related to the racial specificity of GC. Although XBP1 has not been related to gastric cancer so far, it is the only overlapping transcription factor (TF) in the three top-100 DGR lists across Chinese, Korean and American. By integrating our DRN analysis results to prior knowledge, we proposed a hypothesis of dysfunctional regulation mechanisms for gastric carcinogenesis around XBP1 in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. XBP1 and its DRLs seem to play crucial roles during gastric carcinogenesis across three racial groups.</p><p id="Par43">The previous studies on the effects of racial factors on gastric cancer were mainly focused on statistics of clinical phenotypes, such as metastasis and survival [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR74">74</xref>&#x02013;<xref ref-type="bibr" rid="CR76">76</xref>], and a few of literatures also reported genetic polymorphisms [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR77">77</xref>]. By means of differential regulation analysis, our cross-racial meta-analysis of gastric cancer demonstrated the complexity and diversity in terms of differential networking, and made an insightful complement to these previous reports. The race specific and common cross-racial DRGs and DRLs are helpful to decipher the phenotypic differences among different racial GC groups from the perspective of transcriptional regulation, and helpful to discover universal or race specific drug targets or biomarkers.</p><p id="Par44">The current work provides a differential networking meta-analysis framework which presents high cohesion and low coupling. This framework is extendable and adaptable to the studies on the regulation mechanisms of other cancer and even other phenotypic changes.</p></sec><sec id="Sec11"><title>Conclusions</title><p id="Par45">Our study aimed at investigating the common dysregulation mechanisms of gastric carcinogenesis across racial groups from three Gastric Carcinoma datasets (GSE54129, GSE24375 and TCGA-STAD) for Chinese, Korean and American. We constructed a cross-racial integrative analysis framework from the viewpoint of differential regulation. The cross-racial meta-analysis of gastric cancer demonstrated the complexity and diversity of gastric carcinogenesis, and provided useful clues for understanding the common dysfunctional regulation mechanisms of gastric cancer progression. In addition, the differential networking meta-analysis framework presented here is extendable and adaptable to the studies on the regulation mechanisms of other cancer and even other phenotypic changes.</p></sec><sec sec-type="supplementary-material"><title>Additional files</title><sec id="Sec12"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12918_2018_564_MOESM1_ESM.docx"><label>Additional file 1:</label><caption><p>Supplementary Figure and legends. <bold>Figure S1.</bold> Quality assessment of our data set (GSE54129). <bold>Figure S2.</bold> Expression level distribution of genes in three datasets. <bold>Figure S3.</bold> The differential networking meta-analysis framework. <bold>Figure S4.</bold> The GIF expression in different patient groups based on Neoplasm Histologic Grade. (DOCX 1497&#x000a0;kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12918_2018_564_MOESM2_ESM.xlsx"><label>Additional file 2:</label><caption><p><bold>Table S1.</bold> DRN meta-analysis of gastric cancer, <ext-link ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn10154163">https://www.synapse.org/#!Synapse:syn10154163</ext-link> (XLSX 98&#x000a0;kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>DCEA</term><def><p id="Par4">Differential CoExpression Analysis</p></def></def-item><def-item><term>DCG</term><def><p id="Par5">Differential co-expression gene</p></def></def-item><def-item><term>DCL</term><def><p id="Par6">Differential co-expression gene link</p></def></def-item><def-item><term>DRG</term><def><p id="Par7">Differentially regulated gene</p></def></def-item><def-item><term>DRL</term><def><p id="Par8">Differentially regulated gene link</p></def></def-item><def-item><term>DRN</term><def><p id="Par9">Differential regulation networking</p></def></def-item><def-item><term>GC</term><def><p id="Par10">Gastric Carcinoma</p></def></def-item><def-item><term>GRN</term><def><p id="Par11">Gene regulatory network</p></def></def-item><def-item><term>STAD</term><def><p id="Par12">Stomach adenocarcinoma</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (10.1186/s12918-018-0564-z) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p><sec id="FPar1"><title>Funding</title><p id="Par46">This work was supported by the grants from the Shanghai Sailing Program (16YF1408600), the National Natural Science Foundation of China (81672736 and 91529302), Shanghai Municipal Commission of Science and Technology (15ZR1430300 and 14DZ2252000), and the administrative committee of Shanghai Zhangjiang Hi-Teck Park (2016&#x02013;08). The cost of publication for this paper was covered by the Shanghai Sailing Program (16YF1408600).</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par47">All data generated or analysed during this study are included in this published article and its supplementary information files.</p></sec><sec id="FPar3"><title>About this supplement</title><p id="Par48">This article has been published as part of <italic>BMC Systems Biology</italic> Volume 12 Supplement 4, 2018: Selected papers from the 11th International Conference on Systems Biology (ISB 2017). The full contents of the supplement are available online at <ext-link ext-link-type="uri" xlink:href="https://bmcsystbiol.biomedcentral.com/articles/supplements/volume-12-supplement-4">https://bmcsystbiol.biomedcentral.com/articles/supplements/volume-12-supplement-4</ext-link>.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>WD and YYL contributed to the design and conception of the study. WD and QL conducted computational experiments, analyzed and interpreted data, developed the analysis framework and drafted the manuscript. BYL joined in the processing of data materials and helped to improve the manuscript. YYL and YXL conceived of the project and participated in its design, helped to analyze and interpret the data and drafted the manuscript. All authors have read and approved the manuscript for publication.</p></notes><notes notes-type="COI-statement"><sec id="FPar4"><title>Ethics approval and consent to participate</title><p id="Par49">Not applicable.</p></sec><sec id="FPar5"><title>Consent for publication</title><p id="Par50">Not applicable.</p></sec><sec id="FPar6"><title>Competing interests</title><p id="Par51">The authors declare that they have no competing interests.</p></sec><sec id="FPar7"><title>Publisher&#x02019;s Note</title><p id="Par52">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueiredo</surname><given-names>C</given-names></name><name><surname>Garcia-Gonzalez</surname><given-names>MA</given-names></name><name><surname>Machado</surname><given-names>JC</given-names></name></person-group><article-title>Molecular pathogenesis of gastric cancer</article-title><source>Helicobacter</source><year>2013</year><volume>18</volume><issue>Suppl 1</issue><fpage>28</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1111/hel.12083</pub-id><?supplied-pmid 24011242?><pub-id pub-id-type="pmid">24011242</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Miller</surname><given-names>KD</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Cancer statistics, 2016</article-title><source>CA Cancer J Clin</source><year>2016</year><volume>66</volume><issue>1</issue><fpage>7</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.3322/caac.21332</pub-id><?supplied-pmid 26742998?><pub-id pub-id-type="pmid">26742998</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGuire</surname><given-names>S</given-names></name></person-group><article-title>World cancer report 2014. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO press</article-title><source>Adv Nutr</source><year>2015</year><volume>7</volume><issue>2</issue><fpage>418</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.3945/an.116.012211</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffart</surname><given-names>TE</given-names></name><name><surname>Carvalho</surname><given-names>B</given-names></name><name><surname>van Grieken</surname><given-names>NC</given-names></name><name><surname>van Wieringen</surname><given-names>WN</given-names></name><name><surname>Tijssen</surname><given-names>M</given-names></name><name><surname>Kranenbarg</surname><given-names>EM</given-names></name><name><surname>Verheul</surname><given-names>HM</given-names></name><name><surname>Grabsch</surname><given-names>HI</given-names></name><name><surname>Ylstra</surname><given-names>B</given-names></name><name><surname>van de Velde</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer</article-title><source>Oncologist</source><year>2012</year><volume>17</volume><issue>5</issue><fpage>653</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.2010-0379</pub-id><?supplied-pmid 22531355?><pub-id pub-id-type="pmid">22531355</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holbrook</surname><given-names>JD</given-names></name><name><surname>Parker</surname><given-names>JS</given-names></name><name><surname>Gallagher</surname><given-names>KT</given-names></name><name><surname>Halsey</surname><given-names>WS</given-names></name><name><surname>Hughes</surname><given-names>AM</given-names></name><name><surname>Weigman</surname><given-names>VJ</given-names></name><name><surname>Lebowitz</surname><given-names>PF</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name></person-group><article-title>Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine</article-title><source>J Transl Med</source><year>2011</year><volume>9</volume><fpage>119</fpage><pub-id pub-id-type="doi">10.1186/1479-5876-9-119</pub-id><?supplied-pmid 21781349?><pub-id pub-id-type="pmid">21781349</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>HR</given-names></name><name><surname>Kim</surname><given-names>HN</given-names></name><name><surname>Kweon</surname><given-names>SS</given-names></name><name><surname>Choi</surname><given-names>JS</given-names></name><name><surname>Shim</surname><given-names>HJ</given-names></name><name><surname>Cho</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>IJ</given-names></name><name><surname>Park</surname><given-names>YK</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>YD</given-names></name><etal/></person-group><article-title>Genetic variations in the PRKAA1 and ZBTB20 genes and gastric cancer susceptibility in a Korean population</article-title><source>Mol Carcinog</source><year>2013</year><volume>52</volume><fpage>E155</fpage><pub-id pub-id-type="doi">10.1002/mc.22063</pub-id><?supplied-pmid 23861218?><pub-id pub-id-type="pmid">23861218</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Kan</surname><given-names>J</given-names></name><name><surname>Yuen</surname><given-names>ST</given-names></name><name><surname>Shi</surname><given-names>ST</given-names></name><name><surname>Chu</surname><given-names>KM</given-names></name><name><surname>Law</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>TL</given-names></name><name><surname>Kan</surname><given-names>Z</given-names></name><name><surname>Chan</surname><given-names>AS</given-names></name><name><surname>Tsui</surname><given-names>WY</given-names></name><etal/></person-group><article-title>Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer</article-title><source>Nat Genet</source><year>2011</year><volume>43</volume><issue>12</issue><fpage>1219</fpage><lpage>1223</lpage><pub-id pub-id-type="doi">10.1038/ng.982</pub-id><?supplied-pmid 22037554?><pub-id pub-id-type="pmid">22037554</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Eun</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Nam</surname><given-names>SW</given-names></name><name><surname>Rhee</surname><given-names>H</given-names></name><name><surname>Koh</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name></person-group><article-title>Gene expression changes in patient-matched gastric normal mucosa, adenomas, and carcinomas</article-title><source>Exp Mol Pathol</source><year>2011</year><volume>90</volume><issue>2</issue><fpage>201</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.yexmp.2010.12.004</pub-id><?supplied-pmid 21185829?><pub-id pub-id-type="pmid">21185829</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>XM</given-names></name><name><surname>Shao</surname><given-names>XQ</given-names></name><name><surname>Meng</surname><given-names>XX</given-names></name><name><surname>Zhang</surname><given-names>XN</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>SX</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>HS</given-names></name></person-group><article-title>Genome-wide analysis of microRNA and mRNA expression signatures in hydroxycamptothecin-resistant gastric cancer cells</article-title><source>Acta Pharmacol Sin</source><year>2011</year><volume>32</volume><issue>2</issue><fpage>259</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1038/aps.2010.204</pub-id><?supplied-pmid 21293479?><pub-id pub-id-type="pmid">21293479</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>WJ</given-names></name><name><surname>Wu</surname><given-names>HL</given-names></name><name><surname>He</surname><given-names>BS</given-names></name><name><surname>Zhang</surname><given-names>YS</given-names></name><name><surname>Zhang</surname><given-names>ZY</given-names></name></person-group><article-title>Analysis of long non-coding RNA expression profiles in gastric cancer</article-title><source>World J Gastroenterol</source><year>2013</year><volume>19</volume><issue>23</issue><fpage>3658</fpage><lpage>3664</lpage><pub-id pub-id-type="doi">10.3748/wjg.v19.i23.3658</pub-id><?supplied-pmid 23801869?><pub-id pub-id-type="pmid">23801869</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopal</surname><given-names>G</given-names></name><name><surname>Raja</surname><given-names>UM</given-names></name><name><surname>Shirley</surname><given-names>S</given-names></name><name><surname>Rajalekshmi</surname><given-names>KR</given-names></name><name><surname>Rajkumar</surname><given-names>T</given-names></name></person-group><article-title>SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer</article-title><source>Cancer Genet</source><year>2013</year><volume>206</volume><issue>5</issue><fpage>174</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.cancergen.2013.04.005</pub-id><?supplied-pmid 23830730?><pub-id pub-id-type="pmid">23830730</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>B</given-names></name><name><surname>Dachrut</surname><given-names>S</given-names></name><name><surname>Coral</surname><given-names>H</given-names></name><name><surname>Yuen</surname><given-names>ST</given-names></name><name><surname>Chu</surname><given-names>KM</given-names></name><name><surname>Law</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Leung</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>4</issue><fpage>e29824</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0029824</pub-id><?supplied-pmid 22539939?><pub-id pub-id-type="pmid">22539939</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, Siu HC, Deng S, Chu KM, Law S, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46(6):573&#x02013;82.</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>McCleland</surname><given-names>M</given-names></name><name><surname>Stawiski</surname><given-names>EW</given-names></name><name><surname>Gnad</surname><given-names>F</given-names></name><name><surname>Mayba</surname><given-names>O</given-names></name><name><surname>Haverty</surname><given-names>PM</given-names></name><name><surname>Durinck</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>YJ</given-names></name><name><surname>Klijn</surname><given-names>C</given-names></name><name><surname>Jhunjhunwala</surname><given-names>S</given-names></name><etal/></person-group><article-title>Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer</article-title><source>Nat Commun</source><year>2014</year><volume>5</volume><fpage>3830</fpage><?supplied-pmid 24807215?><pub-id pub-id-type="pmid">24807215</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma[J]. Nature. 2014;513(7517):202-9.</mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Cui J, Yin Y, Ma Q, et al. Comprehensive characterization of the genomic alterations in human gastric cancer[J]. Int J Cancer. 2015;137(1):86-95.</mixed-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Cancer Genome Atlas Research N</collab></person-group><article-title>Comprehensive molecular characterization of gastric adenocarcinoma</article-title><source>Nature</source><year>2014</year><volume>513</volume><issue>7517</issue><fpage>202</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1038/nature13480</pub-id><pub-id pub-id-type="pmid">25079317</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><article-title>Hallmarks of cancer: the next generation</article-title><source>Cell</source><year>2011</year><volume>144</volume><issue>5</issue><fpage>646</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><?supplied-pmid 21376230?><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreeger</surname><given-names>PK</given-names></name><name><surname>Lauffenburger</surname><given-names>DA</given-names></name></person-group><article-title>Cancer systems biology: a network modeling perspective</article-title><source>Carcinogenesis</source><year>2010</year><volume>31</volume><issue>1</issue><fpage>2</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgp261</pub-id><?supplied-pmid 19861649?><pub-id pub-id-type="pmid">19861649</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>MA</given-names></name><name><surname>de Santiago</surname><given-names>I</given-names></name><name><surname>Campbell</surname><given-names>TM</given-names></name><name><surname>Vaughn</surname><given-names>C</given-names></name><name><surname>Hickey</surname><given-names>TE</given-names></name><name><surname>Ross</surname><given-names>E</given-names></name><name><surname>Tilley</surname><given-names>WD</given-names></name><name><surname>Markowetz</surname><given-names>F</given-names></name><name><surname>Ponder</surname><given-names>BA</given-names></name><name><surname>Meyer</surname><given-names>KB</given-names></name></person-group><article-title>Regulators of genetic risk of breast cancer identified by integrative network analysis</article-title><source>Nat Genet</source><year>2016</year><volume>48</volume><issue>1</issue><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/ng.3458</pub-id><?supplied-pmid 26618344?><pub-id pub-id-type="pmid">26618344</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Tu</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>YJ</given-names></name><name><surname>Mao</surname><given-names>JZ</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>YY</given-names></name><name><surname>Li</surname><given-names>YX</given-names></name></person-group><article-title>Combinatorial network of transcriptional regulation and microRNA regulation in human cancer</article-title><source>BMC Syst Biol</source><year>2012</year><volume>6</volume><fpage>61</fpage><pub-id pub-id-type="doi">10.1186/1752-0509-6-61</pub-id><?supplied-pmid 22691419?><pub-id pub-id-type="pmid">22691419</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Fuente</surname><given-names>A</given-names></name></person-group><article-title>From &#x02018;differential expression&#x02019; to &#x02018;differential networking&#x02019; - identification of dysfunctional regulatory networks in diseases</article-title><source>Trends Genet</source><year>2010</year><volume>26</volume><issue>7</issue><fpage>326</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2010.05.001</pub-id><?supplied-pmid 20570387?><pub-id pub-id-type="pmid">20570387</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>R</given-names></name><name><surname>Datta</surname><given-names>S</given-names></name><name><surname>Datta</surname><given-names>S</given-names></name></person-group><article-title>Differential network analysis in human cancer research</article-title><source>Curr Pharm Des</source><year>2014</year><volume>20</volume><issue>1</issue><fpage>4</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.2174/138161282001140113122316</pub-id><?supplied-pmid 23530503?><pub-id pub-id-type="pmid">23530503</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Jia</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>F</given-names></name><name><surname>Yuan</surname><given-names>W</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name></person-group><article-title>Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma</article-title><source>BMC Genomics</source><year>2012</year><volume>13</volume><issue>Suppl 8</issue><fpage>S14</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-13-S8-S14</pub-id><?supplied-pmid 23282077?><pub-id pub-id-type="pmid">23282077</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhamshettiwar</surname><given-names>PB</given-names></name><name><surname>Maetschke</surname><given-names>SR</given-names></name><name><surname>Davis</surname><given-names>MJ</given-names></name><name><surname>Reverter</surname><given-names>A</given-names></name><name><surname>Ragan</surname><given-names>MA</given-names></name></person-group><article-title>Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets</article-title><source>Genome Med</source><year>2012</year><volume>4</volume><issue>5</issue><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1186/gm340</pub-id><pub-id pub-id-type="pmid">22257447</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yosef</surname><given-names>N</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>Gaublomme</surname><given-names>JT</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Awasthi</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Karwacz</surname><given-names>K</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Jorgolli</surname><given-names>M</given-names></name></person-group><article-title>Dynamic regulatory network controlling TH17 cell differentiation</article-title><source>Nature</source><year>2013</year><volume>496</volume><issue>7446</issue><fpage>461</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1038/nature11981</pub-id><?supplied-pmid 23467089?><pub-id pub-id-type="pmid">23467089</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>BH</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Tu</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>YX</given-names></name><name><surname>Li</surname><given-names>YY</given-names></name></person-group><article-title>DCGL: an R package for identifying differentially coexpressed genes and links from gene expression microarray data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><issue>20</issue><fpage>2637</fpage><lpage>2638</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq471</pub-id><?supplied-pmid 20801914?><pub-id pub-id-type="pmid">20801914</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>BH</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>LX</given-names></name><name><surname>Li</surname><given-names>YX</given-names></name><name><surname>Li</surname><given-names>YY</given-names></name></person-group><article-title>DCGL v2.0: an R package for unveiling differential regulation from differential co-expression</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>11</issue><fpage>e79729</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0079729</pub-id><?supplied-pmid 24278165?><pub-id pub-id-type="pmid">24278165</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>BH</given-names></name><name><surname>Ye</surname><given-names>ZQ</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>YX</given-names></name><name><surname>Li</surname><given-names>YY</given-names></name></person-group><article-title>Link-based quantitative methods to identify differentially coexpressed genes and gene pairs</article-title><source>BMC Bioinformatics</source><year>2011</year><volume>12</volume><fpage>315</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-12-315</pub-id><?supplied-pmid 21806838?><pub-id pub-id-type="pmid">21806838</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>MS</given-names></name><name><surname>Liu</surname><given-names>BY</given-names></name><name><surname>Dai</surname><given-names>WT</given-names></name><name><surname>Zhou</surname><given-names>WX</given-names></name><name><surname>Li</surname><given-names>YX</given-names></name><name><surname>Li</surname><given-names>YY</given-names></name></person-group><article-title>Differential network analysis reveals dysfunctional regulatory networks in gastric carcinogenesis</article-title><source>Am J Cancer Res</source><year>2015</year><volume>5</volume><issue>9</issue><fpage>2605</fpage><lpage>2625</lpage><?supplied-pmid 26609471?><pub-id pub-id-type="pmid">26609471</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Y-X</given-names></name><name><surname>Li</surname><given-names>Y-Y</given-names></name></person-group><article-title>Differential regulation analysis reveals dysfunctional regulatory mechanism involving transcription factors and microRNAs in gastric carcinogenesis</article-title><source>Artif Intell Med</source><year>2017</year><volume>77</volume><fpage>12</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.artmed.2017.02.006</pub-id><?supplied-pmid 28545608?><pub-id pub-id-type="pmid">28545608</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang da</surname><given-names>W</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nat Protoc</source><year>2009</year><volume>4</volume><issue>1</issue><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><?supplied-pmid 19131956?><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>SJ</given-names></name><name><surname>Dai</surname><given-names>WT</given-names></name><name><surname>Li</surname><given-names>YX</given-names></name><name><surname>Li</surname><given-names>YY</given-names></name></person-group><article-title>The human disease network in terms of dysfunctional regulatory mechanisms</article-title><source>Biol Direct</source><year>2015</year><volume>10</volume><fpage>60</fpage><pub-id pub-id-type="doi">10.1186/s13062-015-0088-z</pub-id><?supplied-pmid 26450611?><pub-id pub-id-type="pmid">26450611</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>LS</given-names></name><name><surname>Yu</surname><given-names>JL</given-names></name><name><surname>Lu</surname><given-names>XX</given-names></name><name><surname>Ling</surname><given-names>ZQ</given-names></name></person-group><article-title>Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer</article-title><source>Dig Dis Sci</source><year>2013</year><volume>58</volume><issue>2</issue><fpage>414</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1007/s10620-012-2381-3</pub-id><?supplied-pmid 23010741?><pub-id pub-id-type="pmid">23010741</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Duin</surname><given-names>M</given-names></name><name><surname>van Marion</surname><given-names>R</given-names></name><name><surname>Vissers</surname><given-names>KJ</given-names></name><name><surname>Hop</surname><given-names>WC</given-names></name><name><surname>Dinjens</surname><given-names>WN</given-names></name><name><surname>Tilanus</surname><given-names>HW</given-names></name><name><surname>Siersema</surname><given-names>PD</given-names></name><name><surname>van Dekken</surname><given-names>H</given-names></name></person-group><article-title>High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas</article-title><source>Cytogenet Genome Res</source><year>2007</year><volume>118</volume><issue>2&#x02013;4</issue><fpage>130</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1159/000108293</pub-id><?supplied-pmid 18000363?><pub-id pub-id-type="pmid">18000363</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuge</surname><given-names>H</given-names></name><name><surname>Tsurumura</surname><given-names>T</given-names></name><name><surname>Utsunomiya</surname><given-names>H</given-names></name><name><surname>Kise</surname><given-names>D</given-names></name><name><surname>Kuzuhara</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Fujiki</surname><given-names>H</given-names></name><name><surname>Suganuma</surname><given-names>M</given-names></name></person-group><article-title>Structural basis for the Helicobacter pylori-carcinogenic TNF-alpha-inducing protein</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>388</volume><issue>2</issue><fpage>193</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2009.07.121</pub-id><?supplied-pmid 19643085?><pub-id pub-id-type="pmid">19643085</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delage</surname><given-names>B</given-names></name><name><surname>Fennell</surname><given-names>DA</given-names></name><name><surname>Nicholson</surname><given-names>L</given-names></name><name><surname>McNeish</surname><given-names>I</given-names></name><name><surname>Lemoine</surname><given-names>NR</given-names></name><name><surname>Crook</surname><given-names>T</given-names></name><name><surname>Szlosarek</surname><given-names>PW</given-names></name></person-group><article-title>Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer</article-title><source>Int J Cancer</source><year>2010</year><volume>126</volume><issue>12</issue><fpage>2762</fpage><lpage>2772</lpage><?supplied-pmid 20104527?><pub-id pub-id-type="pmid">20104527</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohnuma</surname><given-names>S</given-names></name><name><surname>Miura</surname><given-names>K</given-names></name><name><surname>Horii</surname><given-names>A</given-names></name><name><surname>Fujibuchi</surname><given-names>W</given-names></name><name><surname>Kaneko</surname><given-names>N</given-names></name><name><surname>Gotoh</surname><given-names>O</given-names></name><name><surname>Nagasaki</surname><given-names>H</given-names></name><name><surname>Mizoi</surname><given-names>T</given-names></name><name><surname>Tsukamoto</surname><given-names>N</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Cancer-associated splicing variants of the CDCA1 and MSMB genes expressed in cancer cell lines and surgically resected gastric cancer tissues</article-title><source>Surgery</source><year>2009</year><volume>145</volume><issue>1</issue><fpage>57</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2008.08.010</pub-id><?supplied-pmid 19081476?><pub-id pub-id-type="pmid">19081476</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Kong</surname><given-names>WQ</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name></person-group><article-title>MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas</article-title><source>IUBMB Life</source><year>2012</year><volume>64</volume><issue>7</issue><fpage>628</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1002/iub.1030</pub-id><?supplied-pmid 22539488?><pub-id pub-id-type="pmid">22539488</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buganim</surname><given-names>Y</given-names></name><name><surname>Goldstein</surname><given-names>I</given-names></name><name><surname>Lipson</surname><given-names>D</given-names></name><name><surname>Milyavsky</surname><given-names>M</given-names></name><name><surname>Polak-Charcon</surname><given-names>S</given-names></name><name><surname>Mardoukh</surname><given-names>C</given-names></name><name><surname>Solomon</surname><given-names>H</given-names></name><name><surname>Kalo</surname><given-names>E</given-names></name><name><surname>Madar</surname><given-names>S</given-names></name><name><surname>Brosh</surname><given-names>R</given-names></name><etal/></person-group><article-title>A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><issue>3</issue><fpage>e9657</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0009657</pub-id><?supplied-pmid 20300178?><pub-id pub-id-type="pmid">20300178</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bustin</surname><given-names>SA</given-names></name><name><surname>Li</surname><given-names>SR</given-names></name><name><surname>Dorudi</surname><given-names>S</given-names></name></person-group><article-title>Expression of the Ca2+&#x02212;activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer</article-title><source>DNA Cell Biol</source><year>2001</year><volume>20</volume><issue>6</issue><fpage>331</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1089/10445490152122442</pub-id><?supplied-pmid 11445004?><pub-id pub-id-type="pmid">11445004</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Zhuo</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Si</surname><given-names>JM</given-names></name></person-group><article-title>Converting a microarray signature into a diagnostic test: a trial of custom 74 gene array for clarification and prediction the prognosis of gastric cancer</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>12</issue><fpage>e81561</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0081561</pub-id><?supplied-pmid 24312559?><pub-id pub-id-type="pmid">24312559</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Jang</surname><given-names>HR</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Noh</surname><given-names>SM</given-names></name><name><surname>Song</surname><given-names>KS</given-names></name><name><surname>Kim</surname><given-names>MR</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Yeom</surname><given-names>YI</given-names></name><name><surname>Kim</surname><given-names>NS</given-names></name><name><surname>Yoo</surname><given-names>HS</given-names></name><etal/></person-group><article-title>The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>349</volume><issue>3</issue><fpage>1032</fpage><lpage>1040</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2006.08.128</pub-id><?supplied-pmid 16959213?><pub-id pub-id-type="pmid">16959213</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>ZL</given-names></name><name><surname>Yan</surname><given-names>BY</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>ZM</given-names></name><name><surname>Zhang</surname><given-names>HZ</given-names></name><name><surname>Wang</surname><given-names>MW</given-names></name><name><surname>Zhang</surname><given-names>XH</given-names></name><name><surname>Sun</surname><given-names>XF</given-names></name></person-group><article-title>PINCH expression and its clinicopathological significance in gastric adenocarcinoma</article-title><source>Dis Markers</source><year>2012</year><volume>33</volume><issue>4</issue><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1155/2012/895713</pub-id><?supplied-pmid 22976000?><pub-id pub-id-type="pmid">22976000</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keshari</surname><given-names>RP</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>DD</given-names></name><name><surname>Li</surname><given-names>YF</given-names></name><name><surname>Yuan</surname><given-names>SQ</given-names></name><name><surname>Qiu</surname><given-names>HB</given-names></name><name><surname>Huang</surname><given-names>CY</given-names></name><name><surname>Chen</surname><given-names>YM</given-names></name><name><surname>Xia</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>2</issue><fpage>e87195</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0087195</pub-id><?supplied-pmid 24504018?><pub-id pub-id-type="pmid">24504018</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Sulahian R, Casey F, Shen J, et al. An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer.[J]. Oncogene. 2014;33(49):5637-48.</mixed-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>YJ</given-names></name><name><surname>Song</surname><given-names>JH</given-names></name><name><surname>Yoon</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>WS</given-names></name><name><surname>Nam</surname><given-names>SW</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Park</surname><given-names>WS</given-names></name></person-group><article-title>Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers</article-title><source>Gastric Cancer</source><year>2014</year><volume>17</volume><issue>2</issue><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1007/s10120-013-0277-3</pub-id><?supplied-pmid 23812904?><pub-id pub-id-type="pmid">23812904</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Qian J, Kong X, Deng N, et al. OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer[J]. Gut. 2015;64(1):37-48.</mixed-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Mashima</surname><given-names>H</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Goto</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>W</given-names></name><name><surname>Dohmen</surname><given-names>T</given-names></name><name><surname>Kamada</surname><given-names>K</given-names></name><name><surname>Yoshioka</surname><given-names>M</given-names></name><name><surname>Uchinami</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The roles of interferon regulatory factors 1 and 2 in the progression of human pancreatic cancer</article-title><source>Pancreas</source><year>2014</year><volume>43</volume><issue>6</issue><fpage>909</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1097/MPA.0000000000000116</pub-id><?supplied-pmid 24632547?><pub-id pub-id-type="pmid">24632547</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatenhorst</surname><given-names>L</given-names></name><name><surname>Senner</surname><given-names>V</given-names></name><name><surname>Puttmann</surname><given-names>S</given-names></name><name><surname>Paulus</surname><given-names>W</given-names></name></person-group><article-title>Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility</article-title><source>J Neuropathol Exp Neurol</source><year>2004</year><volume>63</volume><issue>3</issue><fpage>210</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1093/jnen/63.3.210</pub-id><?supplied-pmid 15055445?><pub-id pub-id-type="pmid">15055445</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piao</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Byun</surname><given-names>HS</given-names></name><name><surname>Huang</surname><given-names>SM</given-names></name><name><surname>Hwang</surname><given-names>SK</given-names></name><name><surname>Yang</surname><given-names>KJ</given-names></name><name><surname>Park</surname><given-names>KA</given-names></name><name><surname>Won</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>J</given-names></name><etal/></person-group><article-title>Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death</article-title><source>Cancer Res</source><year>2009</year><volume>69</volume><issue>8</issue><fpage>3397</fpage><lpage>3404</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-3235</pub-id><?supplied-pmid 19318571?><pub-id pub-id-type="pmid">19318571</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>F</given-names></name><name><surname>Tsuda</surname><given-names>H</given-names></name><name><surname>Arao</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Nomura</surname><given-names>H</given-names></name><name><surname>Chiyoda</surname><given-names>T</given-names></name><name><surname>Hirasawa</surname><given-names>A</given-names></name><name><surname>Akahane</surname><given-names>T</given-names></name><name><surname>Nishio</surname><given-names>H</given-names></name><etal/></person-group><article-title>EGRI and FOSB gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapy</article-title><source>Genes Chromosomes Cancer</source><year>2012</year><volume>51</volume><issue>3</issue><fpage>300</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1002/gcc.21916</pub-id><?supplied-pmid 22095904?><pub-id pub-id-type="pmid">22095904</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Juan</surname><given-names>WC</given-names></name><name><surname>Liang</surname><given-names>CR</given-names></name><name><surname>Yeoh</surname><given-names>KG</given-names></name><name><surname>So</surname><given-names>J</given-names></name><name><surname>Chung</surname><given-names>MC</given-names></name></person-group><article-title>S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis</article-title><source>Proteomics Clin Appl</source><year>2012</year><volume>6</volume><issue>3&#x02013;4</issue><fpage>152</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1002/prca.201100050</pub-id><?supplied-pmid 22532451?><pub-id pub-id-type="pmid">22532451</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lozano-Pope</surname><given-names>I</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Matthias</surname><given-names>M</given-names></name><name><surname>Doran</surname><given-names>KS</given-names></name><name><surname>Obonyo</surname><given-names>M</given-names></name></person-group><article-title>Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancer</article-title><source>BMC Cancer</source><year>2017</year><volume>17</volume><issue>1</issue><fpage>133</fpage><pub-id pub-id-type="doi">10.1186/s12885-017-3114-y</pub-id><?supplied-pmid 28201999?><pub-id pub-id-type="pmid">28201999</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkhiri</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Soutto</surname><given-names>M</given-names></name><name><surname>El-Rifai</surname><given-names>W</given-names></name></person-group><article-title>Resistance to TRAIL is mediated by DARPP-32 in gastric cancer</article-title><source>Clin Cancer Res</source><year>2012</year><volume>18</volume><issue>14</issue><fpage>3889</fpage><lpage>3900</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-3182</pub-id><?supplied-pmid 22589394?><pub-id pub-id-type="pmid">22589394</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Hong</surname><given-names>J</given-names></name><name><surname>Tripathi</surname><given-names>MK</given-names></name><name><surname>Sehdev</surname><given-names>V</given-names></name><name><surname>Belkhiri</surname><given-names>A</given-names></name><name><surname>El-Rifai</surname><given-names>W</given-names></name></person-group><article-title>Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells</article-title><source>Mol Cancer Res</source><year>2013</year><volume>11</volume><issue>1</issue><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1158/1541-7786.MCR-12-0243-T</pub-id><?supplied-pmid 23160836?><pub-id pub-id-type="pmid">23160836</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Katsha</surname><given-names>A</given-names></name><name><surname>Hong</surname><given-names>J</given-names></name><name><surname>Belkhiri</surname><given-names>A</given-names></name><name><surname>El-Rifai</surname><given-names>W</given-names></name></person-group><article-title>Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis</article-title><source>Oncogene</source><year>2016</year><volume>35</volume><issue>14</issue><fpage>1847</fpage><lpage>1856</lpage><pub-id pub-id-type="doi">10.1038/onc.2015.250</pub-id><?supplied-pmid 26119931?><pub-id pub-id-type="pmid">26119931</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkhiri</surname><given-names>A</given-names></name><name><surname>Dar</surname><given-names>AA</given-names></name><name><surname>Zaika</surname><given-names>A</given-names></name><name><surname>Kelley</surname><given-names>M</given-names></name><name><surname>El-Rifai</surname><given-names>W</given-names></name></person-group><article-title>T-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism</article-title><source>Cancer Res</source><year>2008</year><volume>68</volume><issue>2</issue><fpage>395</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-1580</pub-id><?supplied-pmid 18199533?><pub-id pub-id-type="pmid">18199533</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>FZ</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>MY</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Hattori</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><etal/></person-group><article-title>Epigenetic regulation of autophagy by the methyltransferase EZH2 through an MTOR-dependent pathway</article-title><source>Autophagy</source><year>2015</year><volume>11</volume><issue>12</issue><fpage>2309</fpage><lpage>2322</lpage><pub-id pub-id-type="doi">10.1080/15548627.2015.1117734</pub-id><?supplied-pmid 26735435?><pub-id pub-id-type="pmid">26735435</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Rocken</surname><given-names>C</given-names></name><name><surname>Hoffmann</surname><given-names>J</given-names></name><name><surname>Kruger</surname><given-names>S</given-names></name><name><surname>Lendeckel</surname><given-names>U</given-names></name><name><surname>Rocco</surname><given-names>A</given-names></name><name><surname>Pastorekova</surname><given-names>S</given-names></name><name><surname>Malfertheiner</surname><given-names>P</given-names></name><name><surname>Ebert</surname><given-names>MP</given-names></name></person-group><article-title>Expression of carbonic anhydrase 9 at the invasion front of gastric cancers</article-title><source>Gut</source><year>2005</year><volume>54</volume><issue>7</issue><fpage>920</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1136/gut.2004.047340</pub-id><?supplied-pmid 15951534?><pub-id pub-id-type="pmid">15951534</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Yashiro</surname><given-names>M</given-names></name><name><surname>Noda</surname><given-names>S</given-names></name><name><surname>Kashiwagi</surname><given-names>S</given-names></name><name><surname>Matsuoka</surname><given-names>J</given-names></name><name><surname>Fuyuhiro</surname><given-names>Y</given-names></name><name><surname>Doi</surname><given-names>Y</given-names></name><name><surname>Hirakawa</surname><given-names>K</given-names></name></person-group><article-title>Expression of a hypoxia-associated protein, carbonic anhydrase-9, correlates with malignant phenotypes of gastric carcinoma</article-title><source>Digestion</source><year>2010</year><volume>82</volume><issue>4</issue><fpage>246</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1159/000297208</pub-id><?supplied-pmid 20588040?><pub-id pub-id-type="pmid">20588040</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giatromanolaki</surname><given-names>A</given-names></name><name><surname>Koukourakis</surname><given-names>MI</given-names></name><name><surname>Sivridis</surname><given-names>E</given-names></name><name><surname>Pastorek</surname><given-names>J</given-names></name><name><surname>Wykoff</surname><given-names>CC</given-names></name><name><surname>Gatter</surname><given-names>KC</given-names></name><name><surname>Harris</surname><given-names>AL</given-names></name></person-group><article-title>Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><issue>21</issue><fpage>7992</fpage><lpage>7998</lpage><?supplied-pmid 11691824?><pub-id pub-id-type="pmid">11691824</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhamshettiwar</surname><given-names>PB</given-names></name><name><surname>Maetschke</surname><given-names>SR</given-names></name><name><surname>Davis</surname><given-names>MJ</given-names></name><name><surname>Reverter</surname><given-names>A</given-names></name><name><surname>Ragan</surname><given-names>MA</given-names></name></person-group><article-title>Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets</article-title><source>Genome medicine</source><year>2012</year><volume>4</volume><issue>5</issue><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/gm340</pub-id><?supplied-pmid 22548828?><pub-id pub-id-type="pmid">22548828</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Xin</surname><given-names>M</given-names></name><name><surname>Feldmann</surname><given-names>KA</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Machine learning-based differential network analysis: a study of stress-responsive transcriptomes in Arabidopsis</article-title><source>Plant Cell</source><year>2014</year><volume>26</volume><issue>2</issue><fpage>520</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1105/tpc.113.121913</pub-id><?supplied-pmid 24520154?><pub-id pub-id-type="pmid">24520154</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname><given-names>R</given-names></name><name><surname>Seno</surname><given-names>S</given-names></name><name><surname>Takenaka</surname><given-names>Y</given-names></name><name><surname>Matsuda</surname><given-names>H</given-names></name></person-group><article-title>An estimation method for a cellular-state-specific gene regulatory network along tree-structured gene expression profiles</article-title><source>Gene</source><year>2013</year><volume>518</volume><issue>1</issue><fpage>17</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2012.11.090</pub-id><?supplied-pmid 23266644?><pub-id pub-id-type="pmid">23266644</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>M</given-names></name><name><surname>Koh</surname><given-names>KX</given-names></name><name><surname>Yeo</surname><given-names>BH</given-names></name><name><surname>Song</surname><given-names>CM</given-names></name><name><surname>Chia</surname><given-names>KS</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Yeoh</surname><given-names>KG</given-names></name><name><surname>Hill</surname><given-names>J</given-names></name><name><surname>Iacopetta</surname><given-names>B</given-names></name><name><surname>Soong</surname><given-names>R</given-names></name></person-group><article-title>Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race</article-title><source>Eur J Cancer</source><year>2009</year><volume>45</volume><issue>14</issue><fpage>2562</fpage><lpage>2568</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2009.03.017</pub-id><?supplied-pmid 19375306?><pub-id pub-id-type="pmid">19375306</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>JC</given-names></name><name><surname>Schnirer</surname><given-names>II</given-names></name><name><surname>Reddy</surname><given-names>S</given-names></name><name><surname>Chiang</surname><given-names>S</given-names></name><name><surname>Najam</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Giacco</surname><given-names>G</given-names></name><name><surname>Hess</surname><given-names>K</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Xie</surname><given-names>K</given-names></name></person-group><article-title>Effects of sex and racial/ethnic group on the pattern of gastric cancer localization</article-title><source>Gastric Cancer</source><year>2002</year><volume>5</volume><issue>4</issue><fpage>0208</fpage><lpage>0212</lpage><pub-id pub-id-type="doi">10.1007/s101200200036</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yachida</surname><given-names>S</given-names></name><name><surname>Wood</surname><given-names>LD</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Takai</surname><given-names>E</given-names></name><name><surname>Totoki</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Luchini</surname><given-names>C</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Hama</surname><given-names>N</given-names></name></person-group><article-title>Genomic sequencing identifies ELF3 as a driver of ampullary carcinoma</article-title><source>Cancer Cell</source><year>2016</year><volume>29</volume><issue>2</issue><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2015.12.012</pub-id><?supplied-pmid 26806338?><pub-id pub-id-type="pmid">26806338</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Cancer Genome Atlas N</collab></person-group><article-title>Comprehensive molecular characterization of human colon and rectal cancer</article-title><source>Nature</source><year>2012</year><volume>487</volume><issue>7407</issue><fpage>330</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1038/nature11252</pub-id><pub-id pub-id-type="pmid">22810696</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleeson</surname><given-names>FC</given-names></name><name><surname>Kerr</surname><given-names>SE</given-names></name><name><surname>Kipp</surname><given-names>BR</given-names></name><name><surname>Voss</surname><given-names>JS</given-names></name><name><surname>Minot</surname><given-names>DM</given-names></name><name><surname>Tu</surname><given-names>ZJ</given-names></name><name><surname>Henry</surname><given-names>MR</given-names></name><name><surname>Graham</surname><given-names>RP</given-names></name><name><surname>Vasmatzis</surname><given-names>G</given-names></name><name><surname>Cheville</surname><given-names>JC</given-names></name></person-group><article-title>Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><issue>34</issue><fpage>54526</fpage><pub-id pub-id-type="doi">10.18632/oncotarget.9440</pub-id><?supplied-pmid 27203738?><pub-id pub-id-type="pmid">27203738</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubio-Perez</surname><given-names>C</given-names></name><name><surname>Tamborero</surname><given-names>D</given-names></name><name><surname>Schroeder</surname><given-names>MP</given-names></name><name><surname>Antolin</surname><given-names>AA</given-names></name><name><surname>Deu-Pons</surname><given-names>J</given-names></name><name><surname>Perez-Llamas</surname><given-names>C</given-names></name><name><surname>Mestres</surname><given-names>J</given-names></name><name><surname>Gonzalez-Perez</surname><given-names>A</given-names></name><name><surname>Lopez-Bigas</surname><given-names>N</given-names></name></person-group><article-title>In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities</article-title><source>Cancer Cell</source><year>2015</year><volume>27</volume><issue>3</issue><fpage>382</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2015.02.007</pub-id><?supplied-pmid 25759023?><pub-id pub-id-type="pmid">25759023</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Juan</surname><given-names>WC</given-names></name><name><surname>Liang</surname><given-names>CR</given-names></name><name><surname>Yeoh</surname><given-names>KG</given-names></name><name><surname>So</surname><given-names>J</given-names></name><name><surname>Chung</surname><given-names>M</given-names></name></person-group><article-title>S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis</article-title><source>Proteomics Clin Appl</source><year>2012</year><volume>6</volume><issue>3&#x02013;4</issue><fpage>152</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1002/prca.201100050</pub-id><?supplied-pmid 22532451?><pub-id pub-id-type="pmid">22532451</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>MM</given-names></name><name><surname>Brada</surname><given-names>N</given-names></name><name><surname>Remacha</surname><given-names>A</given-names></name><name><surname>Badell</surname><given-names>I</given-names></name><name><surname>Ed</surname><given-names>R</given-names></name><name><surname>Baiget</surname><given-names>M</given-names></name><name><surname>Santer</surname><given-names>R</given-names></name><name><surname>Quadros</surname><given-names>EV</given-names></name><name><surname>Rothenberg</surname><given-names>SP</given-names></name><name><surname>Alpers</surname><given-names>DH</given-names></name></person-group><article-title>A genetic polymorphism in the coding region of the gastric intrinsic factor gene (GIF) is associated with congenital intrinsic factor deficiency</article-title><source>Hum Mutat</source><year>2004</year><volume>23</volume><issue>1</issue><fpage>85</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1002/humu.10297</pub-id><?supplied-pmid 14695536?><pub-id pub-id-type="pmid">14695536</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikoma</surname><given-names>N</given-names></name><name><surname>Blum</surname><given-names>M</given-names></name><name><surname>Chiang</surname><given-names>Y-J</given-names></name><name><surname>Estrella</surname><given-names>JS</given-names></name><name><surname>Roy-Chowdhuri</surname><given-names>S</given-names></name><name><surname>Fournier</surname><given-names>K</given-names></name><name><surname>Mansfield</surname><given-names>P</given-names></name><name><surname>Ajani</surname><given-names>J</given-names></name><name><surname>Badgwell</surname><given-names>BD</given-names></name></person-group><article-title>Race is a risk for lymph node metastasis in patients with gastric cancer</article-title><source>Ann Surg Oncol</source><year>2017</year><volume>24</volume><issue>4</issue><fpage>960</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1245/s10434-016-5645-x</pub-id><?supplied-pmid 27778127?><pub-id pub-id-type="pmid">27778127</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>JH</given-names></name><name><surname>Hiles</surname><given-names>JM</given-names></name><name><surname>Leung</surname><given-names>AM</given-names></name><name><surname>Stern</surname><given-names>SL</given-names></name><name><surname>Bilchik</surname><given-names>AJ</given-names></name></person-group><article-title>Race influences stage-specific survival in gastric cancer</article-title><source>Am Surg</source><year>2015</year><volume>81</volume><issue>3</issue><fpage>259</fpage><lpage>267</lpage><?supplied-pmid 25760201?><pub-id pub-id-type="pmid">25760201</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Hendifar</surname><given-names>A</given-names></name><name><surname>Lenz</surname><given-names>C</given-names></name><name><surname>Togawa</surname><given-names>K</given-names></name><name><surname>Lenz</surname><given-names>F</given-names></name><name><surname>Lurje</surname><given-names>G</given-names></name><name><surname>Pohl</surname><given-names>A</given-names></name><name><surname>Winder</surname><given-names>T</given-names></name><name><surname>Ning</surname><given-names>Y</given-names></name><name><surname>Groshen</surname><given-names>S</given-names></name></person-group><article-title>Survival of metastatic gastric cancer: significance of age, sex and race/ethnicity</article-title><source>J Gastrointest Oncol</source><year>2011</year><volume>2</volume><issue>2</issue><fpage>77</fpage><lpage>84</lpage><?supplied-pmid 22811834?><pub-id pub-id-type="pmid">22811834</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>E</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name><name><surname>Cokkinides</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>GK</given-names></name><name><surname>Cardinez</surname><given-names>C</given-names></name><name><surname>Ghafoor</surname><given-names>A</given-names></name><name><surname>Thun</surname><given-names>M</given-names></name></person-group><article-title>Cancer disparities by race/ethnicity and socioeconomic status</article-title><source>CA Cancer J Clin</source><year>2004</year><volume>54</volume><issue>2</issue><fpage>78</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.3322/canjclin.54.2.78</pub-id><?supplied-pmid 15061598?><pub-id pub-id-type="pmid">15061598</pub-id></element-citation></ref></ref-list></back></article>